DE69832202D1 - Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen - Google Patents

Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen

Info

Publication number
DE69832202D1
DE69832202D1 DE69832202T DE69832202T DE69832202D1 DE 69832202 D1 DE69832202 D1 DE 69832202D1 DE 69832202 T DE69832202 T DE 69832202T DE 69832202 T DE69832202 T DE 69832202T DE 69832202 D1 DE69832202 D1 DE 69832202D1
Authority
DE
Germany
Prior art keywords
paclitaxel
analog
intermediate product
partial synthesis
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69832202T
Other languages
English (en)
Other versions
DE69832202T2 (de
Inventor
Ezio Bombardelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of DE69832202D1 publication Critical patent/DE69832202D1/de
Publication of DE69832202T2 publication Critical patent/DE69832202T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69832202T 1997-11-21 1998-11-19 Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen Expired - Fee Related DE69832202T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/975,804 US5917062A (en) 1997-11-21 1997-11-21 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US975804 1997-11-21
PCT/IB1998/001912 WO1999026939A1 (en) 1997-11-21 1998-11-19 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs

Publications (2)

Publication Number Publication Date
DE69832202D1 true DE69832202D1 (de) 2005-12-08
DE69832202T2 DE69832202T2 (de) 2006-07-13

Family

ID=25523419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832202T Expired - Fee Related DE69832202T2 (de) 1997-11-21 1998-11-19 Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen

Country Status (20)

Country Link
US (2) US5917062A (de)
EP (1) EP1049686B9 (de)
JP (1) JP3445973B2 (de)
KR (1) KR100545436B1 (de)
CN (1) CN1229364C (de)
AT (1) ATE308533T1 (de)
AU (1) AU746448C (de)
CA (1) CA2310778C (de)
CZ (1) CZ296350B6 (de)
DE (1) DE69832202T2 (de)
DK (1) DK1049686T3 (de)
ES (1) ES2251106T3 (de)
HK (1) HK1028046A1 (de)
HU (1) HUP0100375A3 (de)
NO (1) NO20002600L (de)
PL (1) PL192422B1 (de)
RU (1) RU2213739C2 (de)
SI (1) SI1049686T1 (de)
SK (1) SK285797B6 (de)
WO (1) WO1999026939A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925926A1 (de) * 1999-06-08 2000-12-14 Bayer Ag Katalysatoren auf Basis Titan-haltiger, organisch-anorganischer Hybridmaterialien zur selektiven Oxidation von Kohlenwasserstoffen
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法
EP2289549A3 (de) 1999-10-01 2011-06-15 Immunogen, Inc. Immunokonjugate für Krebsbehandlung
IT1319682B1 (it) * 2000-12-06 2003-10-23 Indena Spa Procedimento di sintesi del paclitaxel.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20020782A1 (it) * 2002-04-12 2003-10-13 Indena Spa Processo semisintetico per la preparazione di n-debenzoilpaclitaxel
NZ576355A (en) * 2006-10-20 2012-04-27 Scinopharm Singapore Pte Ltd Process for making crystalline anhydrous docetaxel
EP2358693A4 (de) * 2008-11-20 2012-04-18 Reddys Lab Ltd Dr Herstellung von docetaxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34277A (en) * 1862-01-28 Improvement in lamps
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
USRE34277E (en) * 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
MY110249A (en) * 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
CA2071160A1 (en) * 1991-07-31 1993-02-01 Vittorio Farina Asymmetric synthesis of taxol side chain
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5470866A (en) * 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
KR100225535B1 (ko) * 1996-08-27 1999-10-15 정지석 파클리탁셀의 제조방법

Also Published As

Publication number Publication date
ES2251106T3 (es) 2006-04-16
EP1049686B1 (de) 2005-11-02
JP3445973B2 (ja) 2003-09-16
WO1999026939A1 (en) 1999-06-03
SI1049686T1 (sl) 2006-02-28
HK1028046A1 (en) 2001-02-02
ATE308533T1 (de) 2005-11-15
AU746448C (en) 2002-12-05
CN1279677A (zh) 2001-01-10
NO20002600D0 (no) 2000-05-19
CZ20001869A3 (cs) 2000-11-15
EP1049686B9 (de) 2005-12-28
HUP0100375A2 (hu) 2001-12-28
KR100545436B1 (ko) 2006-01-24
SK7322000A3 (en) 2000-11-07
KR20010024619A (ko) 2001-03-26
DE69832202T2 (de) 2006-07-13
DK1049686T3 (da) 2006-01-16
US5917062A (en) 1999-06-29
PL340553A1 (en) 2001-02-12
AU746448B2 (en) 2002-05-02
JP2001524476A (ja) 2001-12-04
SK285797B6 (sk) 2007-08-02
CA2310778A1 (en) 1999-06-03
CZ296350B6 (cs) 2006-02-15
HUP0100375A3 (en) 2002-04-29
CN1229364C (zh) 2005-11-30
RU2213739C2 (ru) 2003-10-10
CA2310778C (en) 2005-02-22
NO20002600L (no) 2000-07-17
AU1170599A (en) 1999-06-15
US5907042A (en) 1999-05-25
PL192422B1 (pl) 2006-10-31
EP1049686A1 (de) 2000-11-08

Similar Documents

Publication Publication Date Title
DE69711395T2 (de) Verfahren zur herstellung von cyclohexen-carboxylatderivate
DE69719201D1 (de) Verfahren zur herstellung von ecteinascidin-verbindungen
MXPA96003822A (es) Aislamiento de material celular bajo visualizacional microscopio.
DE60004217D1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
ATE234304T1 (de) Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte
DE69832202D1 (de) Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
GR3034615T3 (en) Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants.
DE69527787D1 (de) Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
DE60010476D1 (de) Verfahren zur Herstellung eines C-4-Methylcarbonat-Analogons von Paclitaxel
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
ATE387426T1 (de) Verfahren zur herstellung von shogaol und zwischenprodukte für dessen synthese
BA97239A (bs) Novi derivati kumarina postupci za njihovu pripravu i uporaba
BG104073A (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
DE69804853D1 (de) Verfahren zur herstellung von mequitazin und zwischenprodukt der synthese
ATE401303T1 (de) Verfahren zur herstellung von ed-71
ATE162195T1 (de) 4-hydroxy-phenyl-beta-d-glukose-monoester, verfahren zur ihrer herstellung und ihre verwendung in der kosmetik, der pharmazie, als zahnpflegemitteln und lebensmitteln
DE69104816D1 (de) Verfahren zur Herstellung von Ammoniak-Synthesegas.
ATE508109T1 (de) Verfahren zur herstellung von optisch aktiven sulfonamiden und zwischenprodukte zur deren synthese
ATE244262T1 (de) Verfahren zur herstellung von peptidzwischenprodukten
DE69731090D1 (de) Thienylcyclohexan-derivte zur herstellung von thienylcyclohexylen
ATE260267T1 (de) Verfahren zur herstellung von c-4-deacetyltaxanen
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE286879T1 (de) Synthesezwischenprodukte zur herstellung von vitamin d-derivaten
DE69608512D1 (de) Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee